Boehringer Ingelheim achieves further growth in first half of 2012
14 August 2012 | By Boehringer Ingelheim
Boehringer Ingelheim has grown again in the current financial year...
List view / Grid view
14 August 2012 | By Boehringer Ingelheim
Boehringer Ingelheim has grown again in the current financial year...
13 August 2012 | By Patheon
Patheon Inc. announced that Mark J. Kontny is no longer with the company...
13 August 2012 | By Sanofi
Breakthrough device design talks patients and caregivers through the injection process...
13 August 2012 | By Abbott
40 students living with CF each to receive a $2,500 CFCareForward Scholarship...
13 August 2012 | By Roche
First major treatment advance in more than 25 years for sight-threatening condition...
13 August 2012 | By AstraZeneca
NEXIUM 20mg retail launch targeted for 2014, subject to regulatory approval...
10 August 2012 | By Pfizer
Pfizer Inc. announced the Phase 3 INTORACT trial (B1771006) did not meet its primary endpoint...
10 August 2012 | By Roche
Phase III study met its co-primary endpoint...
9 August 2012 | By Phenomenex Inc
Phenomenex introduces two new Tabless Tube Holder accessories...
9 August 2012 | By AstraZeneca
AstraZeneca has made an initial payment of approximately $3.2 billion to Amylin Pharmaceuticals...
9 August 2012 | By Novo Nordisk
Sales grew 17% driven by Victoza®, NovoRapid® and Levemir®...
9 August 2012 | By Pfizer
Nodality, Inc.has announced a strategic collaboration with Pfizer Inc..
8 August 2012 | By H. Lundbeck A/S
H. Lundbeck A/S reports first half revenue of DKK 6,829 million...
8 August 2012 | By Teva Pharmaceutical Industries Ltd
The clinical trial protocol has been granted a Special Protocol Assessment agreement...
8 August 2012 | By Pfizer
Company reaches five-year public goal a year earlier than anticipated...